We are live on ! Find out more
NBTX

Nanobiotix
NBTX

5 hedge funds and large institutions have $17.7M invested in Nanobiotix in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more capital invested

Capital invested by funds: $12.4M → $17.7M (+$5.36M)

25% more funds holding

Funds holding: 4 → 5 (+1)

0.01% more ownership

Funds ownership: 9.93% → 9.94% (+0.01%)

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$4.55K
2
JP Morgan Chase
JP Morgan Chase
New York
+$9

Top Sellers

No sellers this quarter

NBTX Hedge Fund Activity: Q2 2023 in Review

5 of the 6,385 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q2 2023, worth a combined $17.7M — up 43% from $12.4M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new NBTX positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.

The largest buyer was UBS Group, adding an estimated $4.55K.

  • 5 institutional investors held Nanobiotix (NBTX) as of Q2 2023, up from 4 in Q1 2023.
  • Funds reported $17.7M of Nanobiotix stock for Q2 2023, up 43% quarter-over-quarter.
  • 1 fund opened new Nanobiotix positions in Q2 2023 and 0 closed out, a net change of +1 holder.
  • The largest Nanobiotix buyer in Q2 2023 was UBS Group, an estimated $4.55K added.

Based on aggregated 13F filings for Q2 2023.